{"product_id":"scottsdale-interventional-forum-2025","title":"Scottsdale Interventional Forum 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: interventional cardiologists and structural heart specialists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eThe Scottsdale Interventional Forum 2025 provides an advanced clinical update on structural heart disease, complex coronary interventions, and the management of cardiogenic shock. The program focuses on transcatheter valve therapies, innovative PCI techniques, the integration of intravascular imaging, and mechanical circulatory support strategies to optimize patient outcomes in the modern cath lab.\u003c\/p\u003e\n\u003cp\u003eCourse Date: 2025\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eEvaluate and implement the latest transcatheter interventions for structural heart disease, including TAVR, M-TEER, and emerging tricuspid therapies.\u003c\/p\u003e\n\u003cp\u003eApply advanced techniques and intravascular imaging (IVUS) to optimize complex percutaneous coronary interventions (PCI), such as CTOs, bifurcations, and left main disease.\u003c\/p\u003e\n\u003cp\u003eAssess the current evidence and clinical protocols for managing acute cardiogenic shock, utilizing mechanical circulatory support and shock team models.\u003c\/p\u003e\n\u003cp\u003eNavigate complex decision-making in STEMI management, including the debate on complete versus culprit-only revascularization and the timing of mechanical unloading.\u003c\/p\u003e\n\u003cp\u003eFormulate comprehensive management strategies for complex structural and coronary cases, addressing challenges like severe valvular disease with concomitant CAD and vascular access issues.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for interventional cardiologists and structural heart specialists who want advanced updates on TAVR, complex PCI, and cardiogenic shock management.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e01 RCA ISR Management – Stent Boost and IVUS Inform DES Over DCB in Elderly Patient\u003c\/p\u003e\n\u003cp\u003e02 Severe Valvular and Left Main CAD in Frail Patient – DK Crush PCI Strategy and Impella Support\u003c\/p\u003e\n\u003cp\u003e03 Aortic Valve-in-Valve in Lotus Prosthesis – Technical Challenges and Key Lessons\u003c\/p\u003e\n\u003cp\u003e04 Chronic Total Occlusion in RCA With Severe Obesity – Retrograde PCI Strategy and IVUS Guidance\u003c\/p\u003e\n\u003cp\u003e05 Valve-in-Valve in Bicuspid AVR With Dacron Graft – Managing Fracture Limitations\u003c\/p\u003e\n\u003cp\u003e06 CTO in RCA With Persistent Angina – Dual Guide Approach, IVUS Imaging, and Stenting\u003c\/p\u003e\n\u003cp\u003e07 Presentation of a Case – Concomitant AF Ablation and LAA Occlusion\u003c\/p\u003e\n\u003cp\u003e08 Severe MR in a 71-Year-Old – Valve-in-Valve-in-Ring Approach and Deployment Challenges\u003c\/p\u003e\n\u003cp\u003e09 Women’s Heart Disease – Key Symptom Patterns and Early Detection\u003c\/p\u003e\n\u003cp\u003e10 Examples of Escalating MCS in STEMI\u003c\/p\u003e\n\u003cp\u003e11 Mechanical Complications of MI with Cardiogenic Shock – MitraClip Rescue\u003c\/p\u003e\n\u003cp\u003e12 Vascular Access Challenges with MCS\u003c\/p\u003e\n\u003cp\u003e13 Cut, Laser, Drill, and Shock\u003c\/p\u003e\n\u003cp\u003e14 Massive Coronary Thrombosis- Treatment Algorithm and Creative Approaches\u003c\/p\u003e\n\u003cp\u003e15 The Most Difficult Bifurcations- A Step-by-Step Algorithm\u003c\/p\u003e\n\u003cp\u003e16 Approaches to Treating Complex Vein Graft Lesions (and the Native Vessels They Supply)\u003c\/p\u003e\n\u003cp\u003e17 Mitral Transcatheter Edge-to-Edge Repair and Mandatory Mechanical Circulatory Support in Patients with Structural Shock\u003c\/p\u003e\n\u003cp\u003e18 Novel Use of MitraClip to Treat Aortic Regurgitation\u003c\/p\u003e\n\u003cp\u003e19 Intravascular Imaging is Now Class 1A in the European Guidelines – How Should US Interventionalists Respond\u003c\/p\u003e\n\u003cp\u003e20 Leaflet and Septal Modification during ViV TMVR – Rationale, Tips, and Tricks\u003c\/p\u003e\n\u003cp\u003e21 Patient Selectiong for Tricuspid Therapies\u003c\/p\u003e\n\u003cp\u003e22 Optimal TEE and 3D-ICE for Efficient and Effective T-TEER and TTVR\u003c\/p\u003e\n\u003cp\u003e23 Transcatheter Mitral and Tricuspid Valve in Valve Best Practices\u003c\/p\u003e\n\u003cp\u003e25 Aortic Stenosis and Coronary Artery Disease – A Case Presentation\u003c\/p\u003e\n\u003cp\u003e26 Coronary Evaluation and Stenting Pre-TAVR – Neither Cath nor PCI Frequently Necessary\u003c\/p\u003e\n\u003cp\u003e27 Echo Gradients Are Flawed – All BE and SE Valves Do Well!\u003c\/p\u003e\n\u003cp\u003e28 The Transcatheter Valve Journey – Present and Future\u003c\/p\u003e\n\u003cp\u003e29 TAV-in-SAV and TAV-in-TAV – ABCDs of the Pre-Procedural Evaluation\u003c\/p\u003e\n\u003cp\u003e30 Pre TAVR – Cath and Aggressive PCI for All\u003c\/p\u003e\n\u003cp\u003e31 The Data Are Clear – Self-Expanding Superior in Smaller Valves\u003c\/p\u003e\n\u003cp\u003e32 Catheter Based Treatment for Valvular Heart Disease\u003c\/p\u003e\n\u003cp\u003e33 Advances in Coronary Artery Disease Management\u003c\/p\u003e\n\u003cp\u003e34 The Growing Field of Heart Failure Management\u003c\/p\u003e\n\u003cp\u003e35 EVOQUE Tricuspid Valve Replacement\u003c\/p\u003e\n\u003cp\u003e36 Strategies to Prevent Heart Disease\u003c\/p\u003e\n\u003cp\u003e37 Managing Stable CAD in Severe Aortic Stenosis – Insights from NOTION and PCI Strategies\u003c\/p\u003e\n\u003cp\u003e38 Mean Gradient with TEER – Why Higher Gradients Should be Tolerated\u003c\/p\u003e\n\u003cp\u003e39 Optimal Pharmacologic Management Following LAAO\u003c\/p\u003e\n\u003cp\u003e40 Left Atrial Appendage Occlusion – Current Advances, Remaining Challenges\u003c\/p\u003e\n\u003cp\u003e41 M-TEER for Functional MR\u003c\/p\u003e\n\u003cp\u003e42 Putting LAAO Clinical Trials in Perspective\u003c\/p\u003e\n\u003cp\u003e43 How to Treat This 75-Year-Old with Severe Degenerative MR\u003c\/p\u003e\n\u003cp\u003e44 Catheter-Based Therapies for Managing Aortic Insufficiencies\u003c\/p\u003e\n\u003cp\u003e45 Spare the Blade – M-TEER Today!\u003c\/p\u003e\n\u003cp\u003e46 The Data Are Favorable, but Can T-TEER Be Democratized\u003c\/p\u003e\n\u003cp\u003e47 Mitral Debate – No Way – Surgical Repair Rules Today!\u003c\/p\u003e\n\u003cp\u003e48 Understanding FDA T-TEER Trials – Are There Enough Pros\u003c\/p\u003e\n\u003cp\u003e49 The Role of Transcatheter Tricuspid Valve Replacement – Unsuccessful TTEER with Giant Coaptaion Gap\u003c\/p\u003e\n\u003cp\u003e50 CT Guidance in TMVR – Lessons Learned and Evolving Imaging Protocols\u003c\/p\u003e\n\u003cp\u003e51 Tricuspid Regurgitation Impact on TAVR and M-TEER\u003c\/p\u003e\n\u003cp\u003e52 Transcatheter Repair versus Mitral Valve Surgery for Secondary Mitral Regurgitation – Challenges in Trial Design and Interpre…\u003c\/p\u003e\n\u003cp\u003e53 Should There Be Sex-Based Considerations in the Care of the AS Patient\u003c\/p\u003e\n\u003cp\u003e54 Will T-TEER Evolve Similar to M-TEER – an Operators Perpsective\u003c\/p\u003e\n\u003cp\u003e55 Upstream Treatment of AS – Early TAVR, Evolved, TAVR Unload\u003c\/p\u003e\n\u003cp\u003e56 Back to the Basics – Are Exercise Right Heart Catheterizations Mandatory\u003c\/p\u003e\n\u003cp\u003e57 CVD Jeopardy – Cath Lab \u0026amp; ICU Essentials – Arrhythmias, Shock, and Dissection Anticoagulation Pitfalls\u003c\/p\u003e\n\u003cp\u003e58 The Evolution of HFrEF Therapies\u003c\/p\u003e\n\u003cp\u003e59 The Emerging Role of Transcatheter Shunts\u003c\/p\u003e\n\u003cp\u003e60 Evidence-Based Interventions Targeting Valvular Heart Disease in Heart Failure\u003c\/p\u003e\n\u003cp\u003e61 ModulHeart, Aortix and the Novel Support Devices for Heart Management\u003c\/p\u003e\n\u003cp\u003e62 Mea Culpa, Mea Culpa, Mea Maxima Culpa – STEMI Management\u003c\/p\u003e\n\u003cp\u003e63 Left Atrial Coronary Sinus Shunt Case – Salvaging a Disaster\u003c\/p\u003e\n\u003cp\u003e64 The Heartbreak of Substance Use\u003c\/p\u003e\n\u003cp\u003e65 Contemporary Management of STEMISHOCK\u003c\/p\u003e\n\u003cp\u003e66 Cardiac Biomarkers in Acute and Chronic Care\u003c\/p\u003e\n\u003cp\u003e67 Spontaneous Coronary Artery Dissection – Women \u0026amp; Heart Disease\u003c\/p\u003e\n\u003cp\u003e68 Equipoise – Whats That – We Did That Study Already\u003c\/p\u003e\n\u003cp\u003e69 Structural Heart Disease – Evaluation, Management and Postop Care\u003c\/p\u003e\n\u003cp\u003e70 Cryptogenic Stroke – Whats a PFO\u003c\/p\u003e\n\u003cp\u003e71 Surgical vs Transcatheter Approaches in Functional Mitral Regurgitation – Short and Long-Term Data\u003c\/p\u003e\n\u003cp\u003e72 Failure to Cross – Success Begins with Failure\u003c\/p\u003e\n\u003cp\u003e73 Left Main Disease – Management Challenges and PCI vs CABG Decision-Making\u003c\/p\u003e\n\u003cp\u003e74 Making the Cath Lab a Safer Environment – Advances in Radiation Safety\u003c\/p\u003e\n\u003cp\u003e76 Oh, How I Wish That Wouldn’t Have Happened\u003c\/p\u003e\n\u003cp\u003e77 Will There Be New Indications for the Use of DCB in Coronary Intervention\u003c\/p\u003e\n\u003cp\u003e78 CCTA in 2025 – Planning PCI\u003c\/p\u003e\n\u003cp\u003e79 AMI With Cardiogenic Shock and RV Failure – Escalating to ECMO for Hemodynamic Rescue\u003c\/p\u003e\n\u003cp\u003e80 Comprehensive Invasive Physiology Suite – From Diagnosis to Outcomes\u003c\/p\u003e\n\u003cp\u003e81 STEMI vs. Cardiogenic Shock – Understanding the Data on Complete vs. Culprit-Only PCI\u003c\/p\u003e\n\u003cp\u003e82 Expanding Indication for Intravascular Lithotripsy\u003c\/p\u003e\n\u003cp\u003e83 Restore EF, Protect III, Protect IV – Where Is the Data Leading\u003c\/p\u003e\n\u003cp\u003e85 Acute Cardiogenic Shock Management\u003c\/p\u003e\n\u003cp\u003e86 STEMI Management – Unloading Before Revascularization – Clinical Implications\u003c\/p\u003e\n\u003cp\u003e87 Elective Multivessel CAD and the Evidence for Complete Revascularization\u003c\/p\u003e\n\u003cp\u003e88 How Shock Teams Are Changing the Landscape of Cardiogenic Shock Management\u003c\/p\u003e\n\u003cp\u003e89 Mechanical Circulatory Support for Cardiogenic Shock – Back to the Basics\u003c\/p\u003e\n\u003cp\u003e90 Preventing Plaque Instability and MI – ACS Is the End, Not the Beginning\u003c\/p\u003e\n\u003cp\u003e91 Arrhythmia Management – SVT, PAT, vs AF – Which One Is It\u003c\/p\u003e\n\u003cp\u003e92 The Practice of Knuckle-ology – Mastering Subintimal Antegrade Revascularization\u003c\/p\u003e\n\u003cp\u003e93 Pulmonary Embolism Management – Case Presentation and Current Guidelines\u003c\/p\u003e\n\u003cp\u003e95 Coronary Microvascular Dysfunction – Case Presentation and Discussion\u003c\/p\u003e\n\u003cp\u003e96 Optimizing PCI Results with IVUS – Trial Results, Evolving Guidelines\u003c\/p\u003e\n\u003cp\u003e97 The Impact of Coronary Sinus Reducer on Refractory Angina and Microvascular Dysfunction\u003c\/p\u003e\n\u003cp\u003e98 Management of Acutely Decompensated Systolic Heart Failure – What Happened to My Pump\u003c\/p\u003e\n\u003cp\u003e99 Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy\u003c\/p\u003e\n\u003cp\u003e101 Indications for a Pacemaker – Whats a Block\u003c\/p\u003e\n\u003cp\u003e102 Vascular Complications – Cath Lab Digest\u003c\/p\u003e\n\u003cp\u003e103 Mechanical Circulatory Support in Action\u003c\/p\u003e\n\u003cp\u003e104 Acute Coronary Syndrome STEMI vs NSTEMI\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405818941636,"sku":null,"price":67.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Scottsdale-Interventional-Forum-2025.jpg?v=1784216586","url":"https:\/\/medicalcoursespro.com\/products\/scottsdale-interventional-forum-2025","provider":"Medicalcoursespro","version":"1.0","type":"link"}